This message contains My NCBI what's new results from the National Center for Biotechnology Information (NCBI) at the U.S. National Library of Medicine (NLM).
Do not reply directly to this message.
Sender's message:
Sent on Wednesday, 2009 Jun 17Search kinetoplastids OR kinetoplastid OR Kinetoplastida OR "trypanosoma brucei" OR leishmania OR brucei OR leishmaniasis OR "African trypanosomiasis"
Click here to view complete results in PubMed. (Results may change over time.)
To unsubscribe from these e-mail updates click here.
| PubMed Results |
- 1: J Med Microbiol. 2009 Jun 15. [Epub ahead of print]
-
A pro-apoptotic effect of Landrace of Piper betle- Bangla Mahoma on Leishmania donovani may be due to high content of eugenol.
1 Central Drug Research Institute;
In the absence of effective and safe treatment of Kala-azar (VL) - a most devastating parasitic disease caused by Leishmania donovani a need for the search of antileishmanial from natural resources, in common use, is imperative. Recently, a comparative in vitro antileishmanial activity of methanolic extract of two landraces of Piper betle- Bangla Mahoba (PB-BMM) and Kapoori Vellaikodi (PB-KVM) has been reported. Herein, the putative pathway responsible for death induced by the effective extract of PB-BMM in promastigotes as well as intracellular amastigotes form of L. donovani was assessed using various biochemical approaches. It was observed that PB-BM is capable of selectively inhibiting both the stages of Leishmania parasites by accelerating apoptotic events by generation of ROS targeting mitochondrion without any cytotoxicity to macrophages. Study was extended to reason out the presence/absence of activity in PB-BMM and PB-KVM on the basis of differences in essential oil composition present in methanolic extract assessed by gas chromatography and mass spectra. The essential oil from PB-BM was found to be rich in eugenol as compared to PB-KV. The antileishmanial efficacy of PB-BMM mediated through apoptosis is probably due to the higher content of eugenol in active landrace. This observation emphasizes the need of extending the studies related to traditional medicines from bioactive plants below species to gender/landrace level for better efficacy and reproducibility.
PMID: 19528177 [PubMed - as supplied by publisher]
-
Related articles
- An ethanolic extract of leaves of Piper betle (Paan) Linn mediates its antileishmanial activity via apoptosis.
Parasitol Res. 2008 May; 102(6):1249-55. Epub 2008 Feb 15.
[Parasitol Res. 2008]
- Antileishmanial activity of Eugenol-rich essential oil from Ocimum gratissimum.
Parasitol Int. 2006 Jun; 55(2):99-105. Epub 2005 Dec 15.
[Parasitol Int. 2006]
- The n-hexane and chloroform fractions of Piper betle L. trigger different arms of immune responses in BALB/c mice and exhibit antifilarial activity against human lymphatic filarid Brugia malayi.
Int Immunopharmacol. 2009 Jun; 9(6):716-28. Epub 2009 Mar 10.
[Int Immunopharmacol. 2009]
- ReviewAntiparasitic chemotherapy: tinkering with the purine salvage pathway.
Adv Exp Med Biol. 2008; 625:116-32.
[Adv Exp Med Biol. 2008]
- ReviewPhenotypical characteristics, biochemical pathways, molecular targets and putative role of nitric oxide-mediated programmed cell death in Leishmania.
Parasitology. 2006; 132 Suppl:S19-32.
[Parasitology. 2006]
- » See reviews... | » See all...
- An ethanolic extract of leaves of Piper betle (Paan) Linn mediates its antileishmanial activity via apoptosis.
-
First total synthesis and antiprotozoal activity of (Z)-17-methyl-13-octadecenoic acid, a new marine fatty acid from the sponge Polymastia penicillus.
Department of Chemistry, University of Puerto Rico, P.O. Box 23346, San Juan, Puerto Rico 00931-3346, USA.
The first total synthesis for the (Z)-17-methyl-13-octadecenoic acid was accomplished in seven steps and in a 45% overall yield. The use of (trimethylsilyl)acetylene was key in the synthesis. Based on a previous developed strategy in our laboratory the best synthetic route towards the title compound was first acetylide coupling of (trimethylsilyl)acetylene to the long-chain protected 12-bromo-1-dodecanol followed by a second acetylide coupling to the short-chain 3-methyl-1-bromobutane, which resulted in higher yields. Complete spectral data is also presented for the first time for this recently discovered fatty acid. The title compound displayed antiprotozoal activity against Leishmania donovani (EC(50) = 19.8mug/ml) and inhibited the leishmania DNA topoisomerase IB at concentrations of 50muM.
PMID: 19527698 [PubMed - as supplied by publisher]
-
Related articles
- First total syntheses of (Z)-15-methyl-10-hexadecenoic acid and the (Z)-13-methyl-8-tetradecenoic acid.
Chem Phys Lipids. 2007 Jan; 145(1):37-44. Epub 2006 Nov 13.
[Chem Phys Lipids. 2007]
- An improved synthesis for the (Z)-14-methyl-9-pentadecenoic acid and its topoisomerase I inhibitory activity.
ARKIVOC. 2007; 2007(viii):49-57.
[ARKIVOC. 2007]
- New 17-Methyl-13-Octadecenoic and 3,16-Docosadienoic Acids from the Sponge Polymastia penicillus.
Lipids. 2009 Mar 6; . Epub 2009 Mar 6.
[Lipids. 2009]
- ReviewNew bioactive fatty acids.
Asia Pac J Clin Nutr. 2008; 17 Suppl 1:192-5.
[Asia Pac J Clin Nutr. 2008]
- ReviewMicrobial/enzymatic synthesis of chiral drug intermediates.
Adv Appl Microbiol. 2000; 47:33-78.
[Adv Appl Microbiol. 2000]
- » See reviews... | » See all...
- First total syntheses of (Z)-15-methyl-10-hexadecenoic acid and the (Z)-13-methyl-8-tetradecenoic acid.
-
CTL responses to Leishmania mexicana gp63-cDNA vaccine in a murine model.
School of Science and Technology, Nottingham Trent University, Clifton, Nottingham, UK. selman.ali@ntu.ac.uk
Immunity to Leishmania is believed to be strongly dependent upon the activation of Th1 immune responses, although the exact role of cytotoxic T lymphocytes (CTLs) has not yet been determined. The aims of this study were to establish a suitable cytotoxicity assay to measure CTL activity and to compare immunity induced by Leishmania mexicana gp63 cDNA via i.m. injection and gene gun immunization in the BALB/c mouse model. The CTL activity was evaluated by short-term (51)Cr-release cytotoxicity assays against CT26 tumour cells transfected with L. mexicana gp63 cDNA and dendritic cells (DCs) loaded with soluble Leishmania antigen (SLA) as targets. The results clearly demonstrated that higher protection to L. mexicana infection was induced by gene gun DNA-immunization vs. i.m. injection. Cytotoxic T lymphocyte activity of splenocytes was observed in mice immunized either with L. mexicana gp63 cDNA or SLA and long-lived CTL activity was observed in immunized and/or re-challenged mice but not naïve mice infected with the parasite.
PMID: 19527453 [PubMed - in process]
-
Related articles
- Genetic immunization with glycoprotein 63 cDNA results in a helper T cell type 1 immune response and protection in a murine model of leishmaniasis.
Hum Gene Ther. 1998 Sep 1; 9(13):1899-907.
[Hum Gene Ther. 1998]
- Immunogenicity of a Salmonella typhi CVD 908 candidate vaccine strain expressing the major surface protein gp63 of Leishmania mexicana mexicana.
Vaccine. 1998 May-Jun; 16(9-10):1043-52.
[Vaccine. 1998]
- The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen.
Int J Oncol. 2006 Apr; 28(4):947-53.
[Int J Oncol. 2006]
- Review[Novel vaccines against M. tuberculosis]
Kekkaku. 2006 Dec; 81(12):745-51.
[Kekkaku. 2006]
- ReviewDendritic cell gene therapy.
Surg Oncol Clin N Am. 2002 Jul; 11(3):645-60.
[Surg Oncol Clin N Am. 2002]
- » See reviews... | » See all...
- Genetic immunization with glycoprotein 63 cDNA results in a helper T cell type 1 immune response and protection in a murine model of leishmaniasis.
-
Secondary bacterial infection in plasma endotoxin levels and the acute-phase response of mice infected with Trypanosoma brucei brucei.
Department of Biochemistry and Molecular Biology, Egerton University, Egerton Njoro, Kenya. ramuch68@yahoo.com
Murine Trypanosoma brucei brucei infection leads to elevated plasma endotoxin-like activity levels not related to parasitaemia levels accompanied by the development of acute-phase response and increased plasma levels of serum amyloid P (SAP) and haptoglobin (Hp). To determine the source of the endotoxin-like activity and role of secondary bacterial infection in the pathogenesis of trypanosomosis, infected mice were treated with the antibiotic ciprofloxacin. Plasma endotoxin-like activity levels, irrespective of treatment, were elevated three- to fourfold, beginning 7 days after infection. Plasma protein concentrations increased markedly following infection from 7 days after infection (DAI). Peak Hp and SAP concentrations in ciprofloxacin-treated and -untreated infected mice were attained 7 and 14 DAI, respectively. Thereafter, both protein levels gradually declined until the end of the experiment, but Hp levels for non-treated mice declined up to 21 DAI and thereafter significantly increased on 28 and 35 DAI. Whole-trypanosome lysate and the membrane-enriched fraction demonstrated endotoxin-like activity, with the former having higher levels. The results suggest that the endotoxin-like activity in trypanosome fractions and plasma of infected mice is due to the trypanosome. Further elevation of haptoglobin during the late stages of infection in non-treated mice suggests the involvement of secondary bacterial infection.
PMID: 19527451 [PubMed - in process]
-
Related articles
- Lipopolysaccharide binding protein in the acute phase response of experimental murine Trypanosoma brucei brucei infection.
Res Vet Sci. 2009 Jun; 86(3):394-8. Epub 2008 Nov 20.
[Res Vet Sci. 2009]
- Cytokines and the acute phase response in post-treatment reactive encephalopathy of Trypanosoma brucei brucei infected mice.
Parasitol Int. 2001 Mar; 50(1):15-26.
[Parasitol Int. 2001]
- Acute phase response in mice experimentally infected with Trypanosoma congolense: a molecular gauge of parasite-host interaction.
Vet Parasitol. 2008 Jan 25; 151(1):14-20. Epub 2007 Oct 22.
[Vet Parasitol. 2008]
- ReviewAlternative versus classical macrophage activation during experimental African trypanosomosis.
Int J Parasitol. 2001 May 1; 31(5-6):575-87.
[Int J Parasitol. 2001]
- ReviewLopinavir/ritonavir: a review of its use in the management of HIV infection.
Drugs. 2003; 63(8):769-802.
[Drugs. 2003]
- » See reviews... | » See all...
Patient Drug Information
- Ciprofloxacin (Cipro® , Cipro® XR, Proquin® XR)
Ciprofloxacin is used to treat or prevent certain infections caused by bacteria. Ciprofloxacin is also used to treat or prevent anthrax (a serious infection that may be spread on purpose as part of a bioterror attack) in...
- Lipopolysaccharide binding protein in the acute phase response of experimental murine Trypanosoma brucei brucei infection.
-
One Scaffold, Three Binding Modes: Novel and Selective Pteridine Reductase 1 Inhibitors Derived from Fragment Hits Discovered by Virtual Screening.
Division of Biological Chemistry and Drug Discovery, College of Life Sciences, University of Dundee, Dow Street, Dundee DD1 5EH, U.K.
The enzyme pteridine reductase 1 (PTR1) is a potential target for new compounds to treat human African trypanosomiasis. A virtual screening campaign for fragments inhibiting PTR1 was carried out. Two novel chemical series were identified containing aminobenzothiazole and aminobenzimidazole scaffolds, respectively. One of the hits (2-amino-6-chloro-benzimidazole) was subjected to crystal structure analysis and a high resolution crystal structure in complex with PTR1 was obtained, confirming the predicted binding mode. However, the crystal structures of two analogues (2-amino-benzimidazole and 1-(3,4-dichloro-benzyl)-2-amino-benzimidazole) in complex with PTR1 revealed two alternative binding modes. In these complexes, previously unobserved protein movements and water-mediated protein-ligand contacts occurred, which prohibited a correct prediction of the binding modes. On the basis of the alternative binding mode of 1-(3,4-dichloro-benzyl)-2-amino-benzimidazole, derivatives were designed and selective PTR1 inhibitors with low nanomolar potency and favorable physicochemical properties were obtained.
PMID: 19527033 [PubMed - as supplied by publisher]
-
Related articles
- Discovery of potent pteridine reductase inhibitors to guide antiparasite drug development.
Proc Natl Acad Sci U S A. 2008 Feb 5; 105(5):1448-53. Epub 2008 Feb 1.
[Proc Natl Acad Sci U S A. 2008]
- Structures of Leishmania major pteridine reductase complexes reveal the active site features important for ligand binding and to guide inhibitor design.
J Mol Biol. 2005 Sep 9; 352(1):105-16.
[J Mol Biol. 2005]
- Biochemical and genetic tests for inhibitors of Leishmania pteridine pathways.
Exp Parasitol. 1997 Nov; 87(3):157-69.
[Exp Parasitol. 1997]
- ReviewNew approaches to Leishmania chemotherapy: pteridine reductase 1 (PTR1) as a target and modulator of antifolate sensitivity.
Parasitology. 1997; 114 Suppl:S101-10.
[Parasitology. 1997]
- ReviewStrategies for the design of inhibitors of aldose reductase, an enzyme showing pronounced induced-fit adaptations.
Cell Mol Life Sci. 2004 Apr; 61(7-8):783-93.
[Cell Mol Life Sci. 2004]
- » See reviews... | » See all...
- Discovery of potent pteridine reductase inhibitors to guide antiparasite drug development.
No comments:
Post a Comment